Botanical species · safety record

Styrax officinalis

The EFSA Compendium of Botanicals holds 6 constituent measurements for Styrax officinalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Styrax officinalis L.

6Constituent measurements
0Safety records
6Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Benzofurans1
  • Eugenol1
  • Isoamericanin a1
  • Lignans1
  • Steroidal saponins1
  • Triterpene saponins1

Plant parts

  • Fruit unspecified2
  • Aerial part of plants1
  • Seed1
  • Stem1
  • Unspecified1
  • stalk1

Preparations

  • Solvent extraction3
  • Essential oil1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
BenzofuransSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
EugenolStem / stalkEssential oil9.9 PercentGC-MSResolve DOI
Isoamericanin aFruit unspecifiedNuclear Magnetic Resonance (NMR)Resolve DOI
Triterpene saponinsFruit unspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
LignansAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
Steroidal saponinsUnspecifiedUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Pazar, Erdinc., Akgul, Yurdanur. Chemical composition of the endocarps of fruits of Styrax officinalis L.. NATURAL PRODUCT RESEARCH, 2015, vol. 29, no. 15, p. 1466-1468. DOI
  2. Segal, R. A new type of saponin from Styrax officinalis. Harokeach Haivri, 1964, p. 104-105.
  3. Yayla, Y., Alankus-Caliskan, O., Anil, H., Bates, RB., Stessman, CC., Kane, VV. Saponins from Styrax officinalis. FITOTERAPIA, 2002, vol. 73, no. 4, p. 320-326. DOI
  4. Ulubelen, A., Saiki, Y., Lotter, H., Chari, V. M., Wagner, H. Chemical components of Styrax officinalis L. IV. The structure of a new lignan styraxin. Planta medica, 1978, p. 403-407.
  5. Tayoub, Ghaleb., Schwob, Isabelle., Bessiere, Jean-Marie., Rabier, Jacques., Masotti, Veronique., Mevy, Jean-Philippe., Ruzzier, Martine., Girard, Gabriel., Viano, Josette. Essential oil composition of leaf, flower and stem of Styrax (Styrax officinalis L.) from south-eastern France . Flavour and fragrance journal, 2006, vol. 21, no. 5, p. 809-812. DOI
  6. Akgul, YY., Anil, H. Benzofurans and another constituent from seeds of Styrax officinalis. PHYTOCHEMISTRY, 2003, vol. 63, no. 8, p. 939-943. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue